-
May 21, 2013
Roche has one of the best long-term growth profiles in the Big Pharma space
-
May 21, 2013
Websense gets a fair deal, given its ongoing growth problems.
-
May 21, 2013
Campbell Soup remains volatile, but investors haven't minded
-
May 21, 2013
A big rally has brought Pfizer back to fair value.
-
May 21, 2013
Tumblr is a high-potential asset, but Yahoo! absolutely must execute.
-
May 17, 2013
Autodesk comes up short again as the macro environment stays soft.
-
May 17, 2013
Brocade badly needs to prove that it can grow again.
-
May 16, 2013
Delivering earnings that were three cents better than analyst expectations along with revenue that was $40 million ...
-
May 15, 2013
With the election of Shinzo Abe and birth of “Abenomics”, things are looking up for Japan's exporting dependent ...
-
May 15, 2013
Even with its problems and challenges, BP seems too cheap today
-
May 14, 2013
Danaher won't stay stuck for long.
-
May 13, 2013
BorgWarner has intriguing growth prospects, but the shares have already recovered quite a bit of ground.
-
May 13, 2013
ABB is executing well in a tough environment, but losing CEO Hogan is a big blow
-
May 13, 2013
Eaton should see very solid growth from here, but the market is already expecting quite a bit of that.
-
May 10, 2013
Investors aren't sold on Nvidia's strategy, and that shows in the stock price.
-
May 09, 2013
Teva's partnership with Alexza looks like an expensive gamble.
-
May 09, 2013
Absent a real competitive moat, it's hard to make sense of Rackspace's valuation.
-
May 09, 2013
Groupon still has a lot of work to do to reassure the Street that this business model is viable
-
May 09, 2013
Will Microsoft pay up to take Nook Media off Barnes & Noble's hands?
-
May 09, 2013
Are investors going to get scalded by this Starbucks-Green Mountain deal?
